Sun Pharma gets US nod for leukaemia drug
Mumbai, Nov 17 (IANS) Indian drug major Sun Pharmaceuticals Tuesday said it has secured tentative approval from the United States Food and Drugs Administration for the generic version of Gleeven, used to treat chronic myeloid leukaemia.
The drug will be available in two strengths of 100 mg and 400 mg and the market size for them is estimated at nearly $900 million, the pharmaceuticals company said in a filing with the stock exchanges.
The shares of the company were, however, down Rs.13.75, or 0.93 percent, at the Bombay Stock Exchange, and were ruling at Rs.1,463.90 some half-hour into the trading session Monday.
Related Posts
Lupin buys anti-cholesterol drug rights for $39 mn
Mumbai, Sep 29 (IANS) Indian pharmaceuticals major Lupin Tuesday said it had acquired the rights for Antara, a drug to treat high blood cholesterol and high triglycerides, for $38.61 million from the US-based Oscient Pharmaceuticals.
The rights for... |
Orchid gets tentative FDA approval for Alzheimer’s drug
The city based Orchid Chemicals & Pharmaceuticals Friday said it has received tentative approval from US Food and Drug Administration (USFDA) for its drug to treat Alzheimer's disease.
According to Orchid, the approval is for the 5mg and 10mg memantine... |
Wockardt gets US nod for Tamsulosin capsules
Chennai, Sep 29 (IANS) Pharma major Wockhardt Tuesday got the US Food and Drug Administration's (USFDA) tentative approval for marketing Tamsulosin Hydrochloride capsules.
Tamsulosin is being used for treating non-cancerous enlargement of prostate,... |
Decks cleared for Orchid to market anti-infectives in US
Chennai, Sep 25 (IANS) Decks have been cleared for the city-based Orchid Chemicals and Pharmaceuticals for marketing the generic versions of Zosyn antibiotic, with a US district court rejecting rival Wyeth Laboratories' motion for a restraint on the... |
Sensex falls steeply, down 0.43 percent
Mumbai, Oct 15 (IANS) A key index of the Indian equity markets was trading on a volatile note early Thursday afternoon and fell sharply to be 0.43 percent below its previous close.
At 12.45 p.m., the sensitive index (Sensex) of the Bombay Stock Exchange... |
New drug ‘can kill leukaemia’
London, Nov 3 (ANI): Scientists from Trinity College Dublin (TCD) have discovered a new drug that can destroy cancerous cells in adult leukaemia patients who have developed resistance to other treatments.
Lead researcher Professor Mark Lawler, of TCD's... |
